Margaret A Gates

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi ABO blood group and breast cancer incidence and survival
    Margaret A Gates
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Int J Cancer 130:2129-37. 2012
  2. ncbi Risk factors for epithelial ovarian cancer by histologic subtype
    Margaret A Gates
    Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115, USA
    Am J Epidemiol 171:45-53. 2010
  3. ncbi Analgesic use and sex steroid hormone concentrations in postmenopausal women
    Margaret A Gates
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 19:1033-41. 2010
  4. ncbi ABO blood group and incidence of epithelial ovarian cancer
    Margaret A Gates
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Int J Cancer 128:482-6. 2011
  5. ncbi Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer
    Margaret A Gates
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 17:2436-44. 2008
  6. ncbi Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations
    Margaret A Gates
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Int J Cancer 124:729-33. 2009
  7. ncbi Flavonoid intake and ovarian cancer risk in a population-based case-control study
    Margaret A Gates
    Department of Medicine, Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Int J Cancer 124:1918-25. 2009
  8. ncbi Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk
    Kathryn L Terry
    Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Carcinogenesis 30:2042-6. 2009
  9. ncbi Risk factors for ductal and lobular breast cancer: results from the nurses' health study
    Joanne Kotsopoulos
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Breast Cancer Res 12:R106. 2010
  10. ncbi MTHFR polymorphisms in relation to ovarian cancer risk
    Kathryn L Terry
    Ob Gyn Epidemiology Center, Brigham and Women s Hospital, Boston, MA 02115, USA
    Gynecol Oncol 119:319-24. 2010

Detail Information

Publications19

  1. ncbi ABO blood group and breast cancer incidence and survival
    Margaret A Gates
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Int J Cancer 130:2129-37. 2012
    ..35-3.86) for B/B, compared to O/O. No significant association was noted between blood type and overall or breast cancer-specific mortality. Our results suggest no association between ABO blood group and breast cancer risk or survival...
  2. ncbi Risk factors for epithelial ovarian cancer by histologic subtype
    Margaret A Gates
    Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115, USA
    Am J Epidemiol 171:45-53. 2010
    ..03). Results suggest that associations with several ovarian cancer risk factors vary by subtype, and these differences are consistent with known similarities between each major histologic subtype and its normal tissue counterpart...
  3. ncbi Analgesic use and sex steroid hormone concentrations in postmenopausal women
    Margaret A Gates
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 19:1033-41. 2010
    ..04). Among postmenopausal women, regular users of aspirin and other analgesics may have lower estrogen levels than nonusers, which could contribute to a decreased risk of breast or ovarian cancer among analgesic users...
  4. ncbi ABO blood group and incidence of epithelial ovarian cancer
    Margaret A Gates
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Int J Cancer 128:482-6. 2011
    ..Additional studies are needed to confirm this association and to explore the mechanisms through which blood group may influence ovarian cancer risk...
  5. ncbi Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer
    Margaret A Gates
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 17:2436-44. 2008
    ..These results suggest that women with certain genetic variants may have a higher risk of ovarian cancer associated with genital talc use. Additional research is needed on these interactions and the underlying biological mechanisms...
  6. ncbi Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations
    Margaret A Gates
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Int J Cancer 124:729-33. 2009
    ..16-1.18 per allele at the alpha=0.05 level in the pooled analysis. Our results do not provide strong support for an association between these breast cancer susceptibility alleles and epithelial ovarian cancer risk...
  7. ncbi Flavonoid intake and ovarian cancer risk in a population-based case-control study
    Margaret A Gates
    Department of Medicine, Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Int J Cancer 124:1918-25. 2009
    ..However, given the findings of previous studies and the biologic plausibility of this association, additional studies are warranted...
  8. ncbi Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk
    Kathryn L Terry
    Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Carcinogenesis 30:2042-6. 2009
    ..Of particular interest was the IGFBP3 SNP rs2270628, which was associated with both increased IGF1 plasma levels and higher ovarian cancer risk...
  9. ncbi Risk factors for ductal and lobular breast cancer: results from the nurses' health study
    Joanne Kotsopoulos
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Breast Cancer Res 12:R106. 2010
    ....
  10. ncbi MTHFR polymorphisms in relation to ovarian cancer risk
    Kathryn L Terry
    Ob Gyn Epidemiology Center, Brigham and Women s Hospital, Boston, MA 02115, USA
    Gynecol Oncol 119:319-24. 2010
    ..Thus, we examined ovarian cancer risk in relation to two functional polymorphisms (C677T and A1298C) in the MTHFR gene...
  11. ncbi A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer
    Margaret A Gates
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA
    Int J Cancer 121:2225-32. 2007
    ..If confirmed, these results would provide an important target for ovarian cancer prevention...
  12. ncbi Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies
    Shelley S Tworoger
    Channing Laboratory, Boston, MA 02115, USA
    Cancer Res 69:1885-91. 2009
    ..34-1.28), and among women with the Ff or ff genotype the OR was 0.71 (95% CI, 0.43-1.18). Our results of an association with the Fok1 VDR polymorphism further support a role of the vitamin D pathway in ovarian carcinogenesis...
  13. ncbi Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer
    Shelley S Tworoger
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Cancer 112:1169-77. 2008
    ..Therefore, the associations between these exposures and ovarian cancer risk were prospectively examined among 110,454 women in the Nurses' Health Study (NHS) for the smoking analyses and 80,253 women for the dietary analyses...
  14. ncbi Validation of tissue microarray technology in ovarian cancer: results from the Nurses' Health Study
    Jonathan L Hecht
    Department of Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Cancer Epidemiol Biomarkers Prev 17:3043-50. 2008
    ..Tissue microarrays (TMAs) allow high-throughput evaluation of protein expression from archived tissue samples. We identified characteristics specific to ovarian cancer that may influence TMA interpretation...
  15. ncbi Perineal use of talcum powder and endometrial cancer risk
    Stalo Karageorgi
    Department of Environmental Health, Harvard School of Public Health, and Department of Medicine, Brigham and Women s Hospital, 677 Huntington Avenue, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 19:1269-75. 2010
    ..However, the relationship between talcum powder use and other gynecologic malignancies such as endometrial cancer has not been examined, and little information is available on nonhormonal risk factors for endometrial cancer...
  16. ncbi Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium
    Linda E Kelemen
    Department of Population Health Research, Alberta Health Services Cancer Care, 1331 29th Street Northwest, Calgary, Alberta T2N4N2, Canada
    Cancer Epidemiol Biomarkers Prev 19:1822-30. 2010
    ....
  17. ncbi Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal women
    Scott R Bauer
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Ave, 3rd Floor, Boston, MA, 02115, USA
    Cancer Causes Control 24:1087-97. 2013
    ..Common analgesics (aspirin, non-aspirin NSAIDs, and acetaminophen) may be associated with hormone-related cancers, possibly via effects on sex hormone and prolactin concentrations...
  18. ncbi ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium
    Elizabeth M Poole
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 181 Longwood Ave, 3rd Floor, Boston, MA 02115, USA
    Cancer Causes Control 23:1805-10. 2012
    ..Previous studies have examined the association between ABO blood group and ovarian cancer risk, with inconclusive results...
  19. ncbi Operating room nursing and lung cancer risk in a cohort of female registered nurses
    Margaret A Gates
    Department of Medicine, Bridham and Women s Hospital and Harvard Medical School, Channing Laboratory, Third Floor, 181 Longwood Avenue, Boston, MA 02115, USA
    Scand J Work Environ Health 33:140-7. 2007
    ..We examined the association between duration of employment as an operating room nurse, a proxy measure for surgical smoke exposure, and subsequent lung cancer risk...